| Metric | Q2 2024 | Q1 2024 | Q2 2023 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.0B | — | — | — | — |
| Op. Income | $234M | — | — | — | — |
| Gross Margin | 22.9% | — | — | — | — |
| Net Margin | 19.1% | — | — | — | — |
| EPS (Diluted) | $1.42 | — | — | — | — |
| Free Cash Flow | -$105M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $1.0B |
| Cost of Revenue | $804M |
| GROSS PROFIT | $238M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $22M |
| Other Expenses | -$18M |
| Operating Expenses | $4M |
| Cost & Expenses | $808M |
| OPERATING INCOME | $234M |
| Interest Income | $17M |
| Interest Expense | $11M |
| Other Income/Expenses | $16M |
| INCOME BEFORE TAX | $250M |
| Income Tax Expense | $39M |
| Net Income from Continuing Ops | $211M |
| Net Income from Discontinued Ops | -$2M |
| Other Adjustments | $0 |
| NET INCOME | $199M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $199M |
| D&A | $83M |
| EBIT | $261M |
| EBITDA | $344M |
| EPS | $2 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $1.0B |
| Cost of Revenue | $804M |
| GROSS PROFIT | $238M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $22M |
| Other Expenses | -$18M |
| Operating Expenses | $4M |
| Cost & Expenses | $808M |
| OPERATING INCOME | $234M |
| Interest Income | $17M |
| Interest Expense | $11M |
| Other Income/Expenses | $16M |
| INCOME BEFORE TAX | $250M |
| Income Tax Expense | $39M |
| Net Income from Continuing Ops | $211M |
| Net Income from Discontinued Ops | -$2M |
| Other Adjustments | $0 |
| NET INCOME | $199M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $199M |
| D&A | $83M |
| EBIT | $261M |
| EBITDA | $344M |
| EPS | $2 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $199M |
| Depreciation & Amortization | $81M |
| Stock-Based Compensation | $2M |
| Deferred Income Tax | $10M |
| Other Non-Cash Items | -$106M |
| Change in Working Capital | -$180M |
| OPERATING CASH FLOW | $8M |
| Capital Expenditure | -$113M |
| Acquisitions (Net) | -$144M |
| Purchases of Investments | -$171M |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $185M |
| NET CASH FROM INVESTING | -$242M |
| Net Debt Issuance | -$2M |
| Common Stock Repurchased | -$700.0K |
| Common Dividends Paid | -$9M |
| Other Financing Activities | -$300.0K |
| NET CASH FROM FINANCING | -$13M |
| FREE CASH FLOW | -$105M |
| Net Change in Cash | -$247M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $622M |
| Short-Term Investments | $0 |
| Net Receivables | $512M |
| Inventory | $422M |
| Other Current Assets | $297M |
| TOTAL CURRENT ASSETS | $1.9B |
| PP&E (Net) | $3.1B |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $750M |
| Tax Assets | $0 |
| Other Non-Current Assets | $159M |
| TOTAL NON-CURRENT ASSETS | $4.0B |
| TOTAL ASSETS | $5.9B |
| Account Payables | $729M |
| Short-Term Debt | $14M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $743M |
| Long-Term Debt | $299M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $47M |
| Other Non-Current Liabilities | $961M |
| TOTAL NON-CURRENT LIABILITIES | $1.4B |
| TOTAL LIABILITIES | $2.2B |
| Common Stock | $2M |
| Additional Paid-In Capital | $4.0B |
| Retained Earnings | $1.3B |
| Treasury Stock | -$1.8B |
| Accum. Other Comp. Income | $162M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $3.7B |
| Minority Interest | $57M |
| TOTAL EQUITY | $3.7B |
| TOTAL LIABILITIES & EQUITY | $5.9B |
| Total Debt | $426M |
| Net Debt | -$196M |
